Recorlev (levoketoconazole), Strongbridge Biopharma's oral investigational therapy for endogenous Cushing's syndrome, resulted in sustained improvements in cortisol and glycemic control in patients with Cushing...
IndustryGrowthInsights (IGI), a leading market research company in its own industry, has published detailed report on Diabetes Drugs Market. This market research report...